E
TELA icon

Ergoteles’s TELA Bio TELA Stock Holding History

Ergoteles’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,297
Closed -$305K – 1587
2021
Q3 		$305K Buy
22,297
+791
+4% +$11K 0.01% 789
2021
Q2 		$346K Buy
+21,506
New +$295K 0.01% 1004

Other funds holding TELA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Ergoteles's TELA Position: Q4 2021 in Review

Ergoteles sold out of TELA Bio (TELA) in Q4 2021, closing a stake of 22,297 shares — an estimated $305K sold.

Ergoteles first reported a position in TELA in Q2 2021 and held it in 2 quarters. The position peaked at $346K in Q2 2021. 36 funds tracked by Wall St. Rank hold TELA as of Q4 2021.

  • Ergoteles reported no remaining TELA Bio position as of Q4 2021 after selling out during the quarter.
  • Ergoteles sold 22,297 TELA Bio shares in Q4 2021, an estimated $305K.
  • Ergoteles first reported a position in TELA Bio in Q2 2021 and held it in 2 quarters.
  • Ergoteles's TELA Bio position peaked at $346K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.